Browse All Topics

Every topic, every region, every level — all within reach.

🏠 Home📰 News📚 Learn📈 Markets🎬 Media
18 Topics
💰Personal Finance
Budgeting, debt, insurance, real estate & life-stage money514 articles
🏛️Government & Fiscal Policy
Fiscal policy, spending & government structure303 articles
🛡️Geopolitics & Defense
War, defense spending, energy & great-power relations287 articles
🗺️Country Profiles
Financial & economic snapshots of individual countries91 articles
🏭Industry Deep Dives
Sector-by-sector analysis of major industries1005 articles
📈Investing & Markets
Stocks, bonds, crypto & investment strategies449 articles
🌍International Economics
Trade, emerging markets & the global economy155 articles
🏦Central Banks & Monetary Policy
The Fed, ECB, BOJ, BOE, PBOC & monetary tools229 articles
🧾Tax Strategy
Tax planning, brackets, deductions & policy44 articles
⚖️Business & Law
Corporate finance, regulation, labor & business structures216 articles
📜Financial History
Crises, crashes & the history of money and markets149 articles
📊Macroeconomics
Inflation, interest rates & economic indicators342 articles
💳Banking & Financial Services
Banks, financial institutions & services137 articles
🤖Innovation & Technology
Tech policy, innovation & the digital economy21 articles
🛢️Energy & Commodities
Energy markets, climate economics & commodities146 articles
⚖️Wealth & Inequality
Income inequality & the distribution of wealth18 articles
🏥Healthcare Economics
Pharma, healthcare spending & medical economics8 articles
Subtopics — Healthcare Economics
Latest in Healthcare Economics
◈ ExplanationAdvancedHealthcare Economics › Pharmaceutical Economics

The Cas12 Consolidation: Why the Mid-Cap Biotech Merger Wave Signals a New Era for Genomic Medicine

While the market's attention remains fixed on GLP-1 weight-loss drug sales, a quiet wave of consolidations among CRISPR-Cas12 innovators is creating a new tier of 'Genomic Platform Giants.' This strategic shift marks the end of the 'Single-Molecule' era and the beginning of the integrated genomic utility model.

4m·👁 2
◈ ExplanationAdvancedHealthcare Economics › Pharmaceutical Economics

The Numbers Behind Medicare and Medicaid — The $1.5 Trillion Federal Health Programs

An examination of the financial mechanics of Medicare and Medicaid, analyzing enrollment demographics, rising per-beneficiary costs, fraud rates, and the projected exhaustion of the Medicare Trust Fund.

4m·👁 9
◈ Explanation📖 StandardAdvancedHealthcare Economics › Pharmaceutical Economics

Pharmaceutical Pricing — Why the Same Drug Costs $10 in Canada and $400 in America

Humira costs $6,922/month in the U.S. and $1,362 in the UK. Insulin costs $300 in the U.S. and $30 in Canada. Here's why drug prices vary so dramatically across countries — and who's right.

4m·👁 7
◈ Explanation📖 StandardAdvancedHealthcare Economics › Pharmaceutical Economics

Hospital Billing — Chargemasters, Negotiated Rates, and the Price Nobody Pays

Hospitals have a 'chargemaster' with prices for every service. Almost nobody pays those prices. Here's how hospital billing actually works — the negotiated rates, the surprise bills, and why a $20 aspirin makes sense in context.

3m·👁 0
◈ Explanation📖 StandardAdvancedHealthcare Economics › Pharmaceutical Economics

Why U.S. Healthcare Costs 2x Other Countries

The U.S. spends $4.5 trillion on healthcare — 18% of GDP. Every other developed country spends 9-12%. The outcomes aren't better. Here's why American healthcare is so expensive.

4m·👁 4
◈ Explanation📖 StandardAdvancedHealthcare Economics › Pharmaceutical Economics

The Global Healthcare Business — Who Profits From Sickness

Healthcare is a $10 trillion global industry. Here's who the major players are — from device makers to hospital chains to pharmaceutical distributors — and how the money flows.

3m·👁 2
◈ Explanation📖 StandardAdvancedHealthcare Economics › Pharmaceutical Economics

Medical Debt — The $220 Billion Crisis That Only Exists in America

100 million Americans carry medical debt. It's the leading cause of personal bankruptcy in the U.S. No other wealthy country has this problem. Here's how medical debt works and why it persists.

3m·👁 7
◈ Explanation📖 StandardAdvancedHealthcare Economics › Pharmaceutical Economics

Health Insurance Economics — How Insurers Make Money Without Caring About You

UnitedHealth Group earned $22 billion in profit in 2023. Health insurers are required to spend 80-85% of premiums on care. Here's how the health insurance business model works.

3m·👁 0
Learn Ladder
Country A–Z